Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

Acta Oncol. 2019 Oct;58(10):1528-1531. doi: 10.1080/0284186X.2019.1629016. Epub 2019 Jul 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Age Factors
  • Brain Neoplasms / epidemiology
  • Brain Neoplasms / prevention & control*
  • Brain Neoplasms / secondary
  • Carcinoma, Non-Small-Cell Lung / epidemiology
  • Carcinoma, Non-Small-Cell Lung / prevention & control*
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Chemoradiotherapy / methods*
  • Clinical Trials, Phase III as Topic
  • Cranial Irradiation*
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / therapy
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Time Factors
  • Treatment Outcome